Get started
Author

Jan Krásenský

Observed names: J Krasensky, J Krásenský, J. KRÁSENSKÝ, J. Krasensky, J. Krásenský, Jan Krasensky, Krasensky, J., Krasensky, Jan, Krásenský, Jan
Observed institutions: The Royal Melbourne Hospital, The University of Melbourne, University of Basel, Charles University, University Hospital of Basel, Don Carlo Gnocchi Foundation, General University Hospital in Prague, University at Buffalo, State University of New York
ORCID: 0000-0002-5605-8821
Observed ORCID: 0000-0002-5605-8821
OpenAlex ID: A5029839989
Functional magnetic resonance imaging during deep brain stimulation: A pilot study in four patients with Parkinson's disease
2001 · Robert Jech, Dušan Urgošík, et al. · Movement Disorders · 172
Subcortical and Cortical Gray Matter Atrophy in a Large Sample of Patients with Clinically Isolated Syndrome and Early Relapsing-Remitting Multiple Sclerosis
2012 · N. Bergsland, D. Horakova, et al. · American Journal of Neuroradiology · 159
PDF
Thalamic Atrophy Is Associated with Development of Clinically Definite Multiple Sclerosis
2013 · Robert Zivadinov, Eva Havrdová, et al. · Radiology · 158
Lipid profiles are associated with lesion formation over 24 months in interferon-β treated patients following the first demyelinating event
2013 · Bianca Weinstock-Guttman, Robert Zivadinov, et al. · Journal of Neurology Neurosurgery & Psychiatry · 123
Evolution of Cortical and Thalamus Atrophy and Disability Progression in Early Relapsing-Remitting MS during 5 Years
2013 · R. Zivadinov, N. Bergsland, et al. · American Journal of Neuroradiology · 107
PDF
Neurofilament levels are associated with blood–brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis
2020 · Tomas Uher, Mason McComb, et al. · Multiple Sclerosis Journal · 86
A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients
2016 · Robert Zivadinov, Tomas Uher, et al. · Multiple Sclerosis Journal · 84
Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis
2009 · E Havrdova, R Zivadinov, et al. · Multiple Sclerosis Journal · 84
Environmental Factors Associated with Disease Progression after the First Demyelinating Event: Results from the Multi-Center SET Study
2013 · Dana Horakova, Robert Zivadinov, et al. · PLoS ONE · 83
PDF
Volumetric MRI Markers and Predictors of Disease Activity in Early Multiple Sclerosis: A Longitudinal Cohort Study
2012 · Tomas Kalincik, Manuela Vaneckova, et al. · PLoS ONE · 82
PDF
Gray matter atrophy patterns in multiple sclerosis: A 10-year source-based morphometry study
2017 · Niels Bergsland, Dana Horakova, et al. · NeuroImage Clinical · 80
PDF
Reliable measurements of brain atrophy in individual patients with multiple sclerosis
2016 · Dirk Smeets, Annemie Ribbens, et al. · Brain and Behavior · 74
Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients
2015 · Kelly Fellows, Tomas Uher, et al. · Journal of Lipid Research · 69
Serum neurofilament light chain reflects inflammation-driven neurodegeneration and predicts delayed brain volume loss in early stage of multiple sclerosis
2020 · Barbora Srpova, Tomas Uher, et al. · Multiple Sclerosis Journal · 64
Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later
2015 · Tomas Uher, Dana Horakova, et al. · Multiple Sclerosis Journal · 56
Multiple Sclerosis and the Accumulation of Iron in the Basal Ganglia: Quantitative Assessment of Brain Iron Using MRI T2 Relaxometry
2010 · A. Burgetova, Z. Seidl, et al. · European Neurology · 55
Diagnostic delay of multiple sclerosis: prevalence, determinants and consequences
2023 · Tomas Uher, Adrian Adzima, et al. · Multiple Sclerosis Journal · 53
PDF
Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosis
2016 · Tomas Uher, Manuela Vaneckova, et al. · Multiple Sclerosis Journal · 51
Serum lipid profile changes predict neurodegeneration in interferon-β1a-treated multiple sclerosis patients
2016 · Tomas Uher, Kelly Fellows, et al. · Journal of Lipid Research · 50
Age-related magnetic susceptibility changes in deep grey matter and cerebral cortex of normal young and middle-aged adults depicted by whole brain analysis
2021 · Romana Burgetova, Petr Dusek, et al. · Quantitative Imaging in Medicine and Surgery · 49
Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome
2014 · Tomas Uher, Jana Blahova-Dusankova, et al. · Journal of Neurology · 49
Evolution of Brain Volume Loss Rates in Early Stages of Multiple Sclerosis
2021 · Tomas Uher, Jan Krasensky, et al. · Neurology Neuroimmunology & Neuroinflammation · 47
PDF
Amygdalar volume and psychiatric symptoms in Alzheimer's disease: an MRI analysis
2005 · D. Horinek, P. Petrovicky, et al. · Acta Neurologica Scandinavica · 46
Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes
2014 · R. W. Browne, B. Weinstock-Guttman, et al. · Journal of Neurology Neurosurgery & Psychiatry · 45
Thalamic Iron Differentiates Primary-Progressive and Relapsing-Remitting Multiple Sclerosis
2017 · A. Burgetova, P. Dusek, et al. · American Journal of Neuroradiology · 42
PDF
Works count: 162
Citation count: 3,048
H-index: 33
I10-index: 68
Year
Topic
Type